or Try an Advanced Search...

    Hematologic Malignancies Stocks List

    Symbol Grade Name % Change
    INCY C Incyte Corporation -0.93
    PRTC C PureTech Health plc 0.39
    KYMR D Kymera Therapeutics, Inc. -1.23
    SLS D SELLAS Life Sciences Group, Inc. -1.61
    CRBU D Caribou Biosciences, Inc. 1.02
    CLLS F Cellectis S.A. -2.62
    INMB F INmune Bio Inc. 4.39
    FATE F Fate Therapeutics, Inc. -6.76
    HOWL F Werewolf Therapeutics, Inc. 8.54
    APTO F Aptose Biosciences, Inc. -10.66
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Solid Tumors Biotechnology Cancer Clinical Medicine Medicine Acute Myeloid Leukemia Life Sciences Biology CD19 Cancer Immunotherapy Cancer Treatment Health Sciences Hematopoietic Stem Cell Immune System Immunology Immunotherapy Leukemia Multiple Myeloma Oncology

    Related ETFs - A few ETFs which own one or more of the above listed Hematologic Malignancies stocks.

    Symbol Grade Name Weight
    IWC B iShares Microcap ETF 0.03
    AVSC B Avantis U.S. Small Cap Equity ETF 0.01
    VTWG B Vanguard Russell 2000 Growth ETF 0.01
    VTI A Vanguard Total Stock Market ETF 0.0
    DFAC A Dimensional U.S. Core Equity 2 ETF 0.0
    View all Hematologic Malignancies ETFs...
    Compare ETFs
    Compare IWC to AVSC Compare IWC to VTWG Compare VTI to DFAC

        Hematologic Malignancies Stocks Recent News

        Date Stock Title
        Nov 21 INCY Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More
        Nov 20 FATE Fate Therapeutics: FT819 Finding Bodes Well For Future Of SLE Treatment Options
        Nov 20 CRBU Caribou Biosciences to Participate in Upcoming Investor Conferences
        Nov 20 HOWL Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference
        Nov 20 APTO Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
        Nov 20 PRTC PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors
        Nov 19 INCY Equities Close Mostly Higher as Nvidia Jumps Ahead of Earnings; Wall Street Tracking Russia-Ukraine Conflict
        Nov 19 INCY Equity Markets Close Mixed Ahead of Nvidia Earnings
        Nov 19 INCY S&P 500 Gains and Losses Today: Supermicro Roars Back After Compliance Filing
        Nov 19 INCY Sector Update: Health Care Stocks Decline
        Nov 19 INCY Top Midday Decliners
        Nov 19 INCY Equities Mixed Intraday Amid Growing Russia-Ukraine Conflict
        Nov 19 INCY Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study
        Nov 19 INCY Incyte seesaws on report of potential Merck takeover interest
        Nov 19 INCY Incyte Stock Slumps After Firm Scraps Drug, Pauses Enrollment in Other Study
        Nov 19 INCY Incyte Is the S&P 500’s Worst Performer Today. What’s Hitting the Stock.
        Nov 19 INCY Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
        Nov 19 INCY Incyte Faces Challenges but Remains Focused on Strategic Growth
        Nov 19 INCY Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.
        Nov 19 FATE Wall Street Breakfast Podcast: Fate Therapeutics Rises On Lupus Drug Data
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Cancer Solid Tumors Advanced Solid Tumors Biopharmaceutical Cancer Immunotherapy Cancer Treatment Checkpoint Inhibitor Disease Health Sciences Immune System Immunotherapy Life Sciences Lymphoma Metastatic Solid Tumors Precision Medicine Residual Disease Treatment Of Cancer Tumors Of The Hematopoietic And Lymphoid Tissues
        Hematologic Malignancies

        Hematologic malignancies are cancers of the blood, bone marrow, and lymphatic system. These cancers can affect the production and function of blood cells, leading to a variety of symptoms and complications. Common types of hematologic malignancies include leukemia, lymphoma, and multiple myeloma. Treatment for hematologic malignancies may include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy.

        Browse All Tags